Marieke H Otten
Overview
Explore the profile of Marieke H Otten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Sonnaville E, van Woensel J, van Goudoever J, Otten M, Teela L, Aarnoudse-Moens C, et al.
Pediatr Crit Care Med
. 2023 Feb;
24(6):484-498.
PMID: 36807306
Objectives: Morbidity after PICU admission for critical illness is a growing concern. Sequelae may occur in various domains of functioning and can only appropriately be determined through structured follow-up. Here,...
2.
Otten M, Buysse C, Buddingh E, Terheggen-Lagro S, von Asmuth E, de Sonnaville E, et al.
Pediatr Crit Care Med
. 2023 Jan;
24(4):289-300.
PMID: 36688688
Objectives: To investigate neurocognitive, psychosocial, and quality of life (QoL) outcomes in children with Multisystem Inflammatory Syndrome in Children (MIS-C) seen 3-6 months after PICU admission. Design: National prospective cohort...
3.
van de Riet L, Otten M, van Karnebeek C, van Woensel J
Crit Care Explor
. 2022 Dec;
4(12):e0798.
PMID: 36506830
Design: Retrospective analysis of data from the nationwide Pediatric Intensive Care Evaluation registry including all PICU admissions in The Netherlands. Setting: All PICUs in The Netherlands. Patients: All PICU patients...
4.
Linssen R, Bem R, Kapitein B, Oude Rengerink K, Otten M, den Hollander B, et al.
Eur J Pediatr
. 2021 Apr;
180(10):3141-3149.
PMID: 33891158
Respiratory syncytial virus (RSV) bronchiolitis causes substantial morbidity and mortality in young children, but insight into the burden of RSV bronchiolitis on pediatric intensive care units (PICUs) is limited. We...
5.
de Groot M, de Neef M, Otten M, van Woensel J, Bem R
J Pediatr Intensive Care
. 2020 Jan;
9(1):34-39.
PMID: 31984155
Clinical assessment of the work of breathing (WOB) remains a cornerstone in respiratory support decision-making in the pediatric intensive care unit (PICU). In this study, we determined the interobserver agreement...
6.
Anink J, van Suijlekom-Smit L, Otten M, Prince F, van Rossum M, Dolman K, et al.
Arthritis Res Ther
. 2015 Aug;
17:200.
PMID: 26249667
Introduction: Approximately 30% of juvenile idiopathic arthritis (JIA) patients fail to respond to anti-TNF treatment. When clinical remission is induced, some patients relapse after treatment has been stopped. We tested...
7.
Nusman C, Anink J, Otten M, van Rossum M, van Rijn R, Maas M, et al.
Eur J Radiol
. 2015 Jun;
84(10):1999-2003.
PMID: 26116967
Objectives: Juvenile idiopathic arthritis (JIA) affects bone mineral density (BMD). Dual-energy X-ray absorptiometry (DXA) is the most widely used technique to determine BMD. Digital X-ray radiogrammetry (DXR) is a feasible...
8.
Anink J, Prince F, Dijkstra M, Otten M, Twilt M, ten Cate R, et al.
Rheumatology (Oxford)
. 2015 Jun;
54(11):1964-9.
PMID: 26078219
Objective: To carry out a longitudinal investigation of functional outcome, health-related quality of life (HRQoL) and treatment strategies in JIA patients who started etanercept >5 years ago. Methods: We approached...
9.
Otten M, Anink J, Prince F, Twilt M, Vastert S, ten Cate R, et al.
Ann Rheum Dis
. 2014 Mar;
74(7):1379-86.
PMID: 24641940
Background: Treatment of juvenile idiopathic arthritis (JIA) has changed dramatically since the introduction of biological agents in 1999. Objective: To evaluate trends in prescription patterns of biological agents and the...
10.
Anink J, Otten M, Gorter S, Prince F, van Rossum M, van den Berg J, et al.
Rheumatology (Oxford)
. 2013 Jun;
52(9):1674-9.
PMID: 23740187
Objectives: To evaluate differences in baseline characteristics between etanercept- and adalimumab-treated JIA patients and to reveal factors that influence the choice between these TNF inhibitors, which are considered equally effective...